Multiomics – Webinars and Online Events

MALDI mass spectrometry imaging has emerged as a powerful technology platform for spatially resolved analysis and visualization of a wide range of molecules – including drugs, metabolites, peptides and more – in pharmaceutical R&D, clinical research and basic science. Advances in MALDI workflows are making the technique more accessible.
In this webinar, our speaker will discuss how a new MALDI workflow can be used to analyze lipids in degenerative disease and Alzheimer’s models, contextualizing lipid distribution by enabling comparison to multiple protein markers.
He’ll also highlight how the new workflow can be applied to the study of tumor subtypes and the tumor microenvironment.

The liver is a very good example of how tissue architecture can influence aging. Composed mainly of hepatocytes, the position of these cells is key to their role and determines changes in their metabolism and aging profile.

Researchers from the Max Planck Institute have conducted an in-depth multiomics analysis of functional and healthy hepatocytes, characterizing transcriptional, epigenetic, lipidomic and functional signatures to understand the effects of aging.

In this webinar, you’ll hear all about their research, including the novel perfusion technology for resected mouse liver that makes it easy and convenient to obtain viable hepatocytes to analyze.

Join expert speakers, Dr. Christopher Mason of Weill Cornell Medicine, and Dr. Michael Roberts of Auburn University, for an enlightening discussion on the profound impacts of spaceflight on human biology and the unique molecular signatures of aging influenced by resistance training.

Mass spectrometry (MS)-based omics technologies have revolutionized our understanding of molecular changes in organisms and are crucial for studying metabolism and related diseases through lipidomics and metabolomics. Despite significant advances, there is still a need for robust analytical methodologies in data acquisition, data processing and annotation.
This webinar will demonstrate how LC-Zeno SWATH DIA outperforms conventional DDA in annotating metabolites and lipids in the model organism Gammarus fossarum. Additionally, the presentation will showcase the effectiveness of electron activated dissociation (EAD) in characterizing lipid species and elucidating metabolite isomers. Finally, the webinar will illustrate how EAD and high-resolution targeted approaches improve structural elucidation and molecular network construction.

In this webinar, we’ll explore how integrating proteomics with systems biology sheds light on the complexities of AD pathology.

In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how the research sheds new light on early-stage lung cancer diagnostics and clinical outcomes and showcase how multiomics approaches are key for characterizing complex diseases.

In this webinar, you’ll learn about the insights you could gain by profiling gene expression and open chromatin from the same cell simultaneously.

Our expert speaker will explore how the findings uncover previously unknown insights into disease biology that can help accelerate the identification of new therapeutic targets and biomarkers.

Join this webinar to discover how to integrate spatial biology and multiomics approaches to reveal the intricate interactions between cancer cells and their environment.

Alzheimer’s disease (AD) is the most common form of dementia in the elderly population. While several peptide and protein biomarkers in cerebrospinal fluid (CSF) have been used for AD diagnosis, an unequivocal diagnosis in the early phases of AD is still lacking.